home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Enzyme Curtails Allergic Reaction To Chitin

  May, 2 2007 21:32
your information resource in human molecular genetics
Chitin, the main component of arthropod exoskeletons, elicits an innate allergic response in mice that can be controlled by a host enzyme, a Nature paper reveals. The discovery may influence the development of novel therapeutics for allergic diseases such as asthma.

Mice treated with the biopolymer chitin develop an allergic response, characterized by a build-up of interleukin-4-expressing innate immune cells. But the symptoms can be abolished by treating the animals with the chitin-degrading mammalian enzyme AMCase, Richard M. Locksley and colleagues report.

Chitin provides structural rigidity to parasitic worms, fungi, crustaceans and insects, and its widespread presence in the natural world may have driven evolutionary pressure among vertebrates to maintain chitin-recognition molecules. Occupations predicted to have high environmental chitin levels, such as shellfish processors, are marked by high incidences of asthma, suggesting that this pathway may play a role in human allergic disease.

Author contact:

Richard M. Locksley (University of California, San Francisco, CA, USA)
E-mail: locksley@medicine.ucsf.edu

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.